Femasys Valuation
| FEMY Stock | USD 1.10 0.05 4.76% |
Today, the firm appears to be undervalued. Femasys shows a prevailing Real Value of $3.07 per share. The current price of the firm is $1.1. Our model computes the value of Femasys from reviewing the firm fundamentals such as Shares Outstanding of 22.9 M, shares owned by insiders of 7.60 %, and Operating Margin of (20.24) % as well as analyzing its technical indicators and probability of bankruptcy.
Price Book 4.0275 | Enterprise Value 23.7 M | Enterprise Value Ebitda 0.2361 | Price Sales 25.3063 | Enterprise Value Revenue 18.7759 |
Undervalued
Today
Please note that Femasys' price fluctuation is risky at this time. Calculation of the real value of Femasys is based on 3 months time horizon. Increasing Femasys' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Femasys is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Femasys Stock. However, Femasys' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.1 | Real 3.07 | Target 9.25 | Hype 1.05 | Naive 1.06 |
The intrinsic value of Femasys' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Femasys' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Femasys helps investors to forecast how Femasys stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Femasys more accurately as focusing exclusively on Femasys' fundamentals will not take into account other important factors: Femasys Total Value Analysis
Femasys is currently expected to have valuation of 23.67 M with market capitalization of 24.04 M, debt of 6.7 M, and cash on hands of 19.12 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Femasys fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
23.67 M | 24.04 M | 6.7 M | 19.12 M |
Femasys Investor Information
The book value of the company was currently reported as 0.85. The company recorded a loss per share of 0.81. Femasys had not issued any dividends in recent years. Based on the key indicators related to Femasys' liquidity, profitability, solvency, and operating efficiency, Femasys is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Femasys Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Femasys has an asset utilization ratio of 3.86 percent. This suggests that the Company is making $0.0386 for each dollar of assets. An increasing asset utilization means that Femasys is more efficient with each dollar of assets it utilizes for everyday operations.Femasys Ownership Allocation
Femasys holds a total of 22.9 Million outstanding shares. Femasys shows 7.6 percent of its outstanding shares held by insiders and 7.25 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Femasys Profitability Analysis
The company reported the previous year's revenue of 1.07 M. Net Loss for the year was (14.25 M) with profit before overhead, payroll, taxes, and interest of 764.28 K.About Femasys Valuation
Our relative valuation model uses a comparative analysis of Femasys. We calculate exposure to Femasys's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Femasys's related companies.Femasys Inc., a biomedical company, focuses on womens healthcare market in the United States. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia. Femasys operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 27 people.
Femasys Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 15.4 M |
Additional Tools for Femasys Stock Analysis
When running Femasys' price analysis, check to measure Femasys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Femasys is operating at the current time. Most of Femasys' value examination focuses on studying past and present price action to predict the probability of Femasys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Femasys' price. Additionally, you may evaluate how the addition of Femasys to your portfolios can decrease your overall portfolio volatility.